Date: 2015-04-07
Type of information: Resignation
Compound:
Company: Flamel Technologies (France)
Therapeutic area:
Type agreement: resignation
Action mechanism:
Disease:
Details: * On April 7, 2015, Flamel Technologies announced that Steve Lisi, the Senior Vice President of Business and Corporate Development at Flamel, has left the Company for personal reasons. The Company will immediately begin a comprehensive search for a permanent replacement and expects to hire a new Vice President of Business and Corporate Development within the next six to eight weeks. Flamel is reaffirming its product revenue guidance for 2015 of $170 to $185 million for combined sales of Bloxiverz™ and Vazculep™.
Financial terms:
Latest news:
